ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 25 Sep 2023
Last Applicant/ Owned by
One Johnson & Johnson Plaza
New Brunswick
NJ
08933
Serial Number
90641216 filed on 13th Apr 2021
Registration Number
N/A
Correspondent Address
Cheryl L. Foytlin
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
TALFANZA
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory dis Read More
Classification Information
Class [005]
Pharmaceutical Products
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Mark Details
Serial Number
No 90641216
Mark Type
No Service/Collective Mark
Attorney Docket Number
No T42160US2
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 25th Sep 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 25th Sep 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 28th Jan 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 26th Jan 2023 | SOU TEAS EXTENSION RECEIVED |
| 26th Jan 2023 | SOU EXTENSION 2 FILED |
| 26th Jan 2023 | SOU EXTENSION 2 GRANTED |
| 10th Aug 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 08th Aug 2022 | SOU TEAS EXTENSION RECEIVED |
| 08th Aug 2022 | SOU EXTENSION 1 FILED |
| 08th Aug 2022 | SOU EXTENSION 1 GRANTED |